Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
842.50    4.00 (0.48%)
Bid:
846.00
Ask:
847.00
Spread: 1.00 (0.118%)
Market Cap: £757.82m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

AGM Trading Update

20 May 2021 07:00

RNS Number : 1972Z
Gamma Communications PLC
20 May 2021
 

20 May 2021

Gamma Communications plc

AGM trading update - Continuing to grow and generate cash

At the Annual General Meeting ("AGM") to be held later today at The Barn, Hobbs Hole Farm, Ledwell Road, Great Tew OX7 4DN, Richard Last, Chairman of Gamma Communications PLC ("Gamma" or the "Group") will read the following statement:-

Group overview

Gamma saw continued growth in the first quarter of the year, with that positive momentum expected to continue as each economy in which the Group operates is anticipated to recover following the pandemic. 

Highlights from 1 January 2021 to date include:

· In its core UK market, Gamma has successfully launched a number of key products (all of which have been well received by both Channel Partners and End Users) -

o Phone Line + is a replacement service for customers who currently use a basic telephone line; it is a cloud based voice application which is easier to adopt than a full UCaaS solution.

o Horizon Contact is our fully integrated Cloud Contact Centre as a Service ("CCaaS") solution.

o An enhanced mobile service which deepens the existing relationship with Three and gives users access to 5G and Wifi calling.

o Customers can now order SoGEA Broadband which allows them to receive broadband without having a traditional phone line.

· Development of new products continues well, and during Q3 our customers will be able to fully integrate their Horizon Cloud PBX with Microsoft Teams.

· In the Netherlands, we have launched video calling and conferencing alongside our existing voice product.

· Gamma's rate of bad debt remains at historically low levels across the group, despite the challenging economic conditions which are affecting our end users.

· Unit additions of key products are in line with historical levels.

· As reported, on 3 March 2021, the Group acquired Mission Labs Limited for £40.2m (on a cash free basis) with up to an additional £6.0m contingent deferred consideration payable over the next three years. The acquisition of Mission Labs will enable Gamma to enhance and expand its cloud contact centre (CCaaS) technology. In addition, the acquisition will enable Gamma to accelerate its digital channel strategy. Mission Labs has a UCaaS technology platform called CircleLoop (www.circleloop.com). Integration of the business is proceeding well and early performance is in line with expectations.

Balance Sheet

Our balance sheet remains strong and underlying trading continues to generate cash. Gamma had £34m in cash at 30 April 2021 having paid approximately £40m in connection with the acquisition of Mission Labs.

Dividend

In our Annual Report we proposed the payment of a final dividend, in respect of the year ended 31 December 2020, of 7.8 pence per share (2019: 7.0 pence), being £7.3 million in cash terms. When added to the 3.9 pence interim dividend (2019: 3.5 pence) this will equate to a total dividend declared of 11.7 pence for the year as a whole (2019: 10.5 pence). The Board continues to recommend the payment of this dividend which will be proposed as a resolution at the AGM later this morning.

Capital Markets Day

The Group will host a Capital Markets Event at 1400 (BST) on Thursday 10 June. This will give additional information about the new products discussed above.

For more information please email Gamma@tulchangroup.com.

Outlook

Based on our trading in the first quarter and the expectation that the UK will not enter into another lockdown period, we anticipate revenue, adjusted EBITDA and adjusted EPS for the year ended 31 December 2021 to be at the higher end of the range of market forecasts*.

The Board will provide its next trading update prior to the publication of the half year results.

* Note: Company compiled consensus is based on forecasts which have been updated to take into account Gamma's 2020 audited results. The ranges are Revenue £442.4m - £461.3m; Adjusted EBITDA £86.0m - £94.0m; and Adjusted EPS 54.9p - 63.1p.

 

Gamma Communications plc

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

Tel: +44 (0) 333 006 5972

 

 

Tulchan Communications LLP

James Macey White / Matt Low

Tel: +44 (0) 207 353 4200

 

 

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 207 597 5970

Patrick Robb / Virginia Bull

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASSNFSFFEFA
Date   Source Headline
13th Mar 20257:05 amRNSHolding(s) in Company
20th Feb 20257:00 amRNSGamma completes acquisition of STARFACE
13th Feb 202510:02 amRNSDirector/PDMR Shareholding
6th Feb 20258:46 amRNSHolding(s) in Company
3rd Feb 20251:00 pmRNSTotal Voting Rights
21st Jan 202512:13 pmRNSHolding(s) in Company
20th Jan 20251:54 pmRNSDirector/PDMR Shareholding
14th Jan 20255:06 pmRNSDirector/PDMR Shareholding
14th Jan 20257:01 amRNSTrading Update
14th Jan 20257:00 amRNSGamma agrees to acquire STARFACE
2nd Jan 20254:47 pmRNSTotal Voting Rights
13th Dec 20242:05 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:48 pmRNSHolding(s) in Company
3rd Dec 20243:42 pmRNSHolding(s) in Company
2nd Dec 202412:37 pmRNSTotal Voting Rights
2nd Dec 20247:00 amRNSProposed Move to the Main Market
14th Nov 20248:05 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSBlock listing Interim Review
4th Nov 20247:00 amRNSTotal Voting Rights - Replacement
1st Nov 20245:45 pmRNSHolding(s) in Company
1st Nov 20242:43 pmRNSTotal Voting Rights
15th Oct 20243:32 pmRNSDirector/PDMR Shareholding
4th Oct 20242:59 pmRNSHolding(s) in Company
2nd Oct 20243:55 pmRNSDirector/PDMR Shareholding
1st Oct 20244:08 pmRNSTotal Voting Rights
27th Sep 20244:27 pmRNSHolding(s) in Company
16th Sep 202410:01 amRNSDirector/PDMR Shareholding
13th Sep 20241:55 pmRNSHolding(s) in Company
11th Sep 20246:21 pmRNSHolding(s) in Company
10th Sep 20247:10 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSHalf-year Report
9th Sep 20247:22 amRNSHolding(s) in Company
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 202412:56 pmRNSTotal Voting Rights
22nd Aug 20243:04 pmRNSHolding(s) in Company
21st Aug 202411:10 amRNSHolding(s) in Company
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSChange of Adviser
14th Aug 20247:05 amRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20241:49 pmRNSHolding(s) in Company
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:49 pmRNSHolding(s) in Company
2nd Aug 20241:40 pmRNSHolding(s) in Company
1st Aug 20248:55 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.